Jane Street Group, LLC Prothena Corp Public LTD CO Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$30.27 - $49.22 $236,106 - $383,916	7,800 Added 121.88%	14,200 $519,000
Q4 2021 Feb 15, 2022	SELL	$42.11 - $73.26 $1.52 Million - $2.64 Million	-36,100 Reduced 84.94%	6,400 $316,000
Q3 2021 Nov 16, 2021	BUY	$48.2 - $78.89 $433,800 - $710,010	9,000 Added 26.87%	42,500 $3.03 Million
Q2 2021 Aug 16, 2021	BUY	$21.63 - $57.65 $545,076 - $1.45 Million	25,200 Added 303.61%	33,500 $1.72 Million
Q1 2018 May 15, 2018	BUY	$27.95 - $45.04 $231,985 - $373,832	8,300 New	8,300 $305,000

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $678M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.